Iron: More than Meets the Eye
Nutrients · 2025
DOI: 10.3390/nu17182964 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Ethan R Naquin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA. Hauptthemen laut MEDLINE: Iron, Iron Overload, Eye Diseases, Eye. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Iron is an essential micronutrient integral to ocular physiology, supporting biochemical processes such as mitochondrial respiration, DNA synthesis and phototransduction. Disruptions in systemic or local iron homeostasis, whether due to overload or deficiency, have been increasingly implicated in the pathogenesis of a broad range of anterior and posterior segment ocular disorders. Iron deficiency may compromise retinal bioenergetics, impair cellular repair, and increase susceptibility to oxidative stress, while iron overload facilitates the generation of reactive oxygen species, contributing to lipid peroxidation, mitochondrial dysfunction, and ferroptosis. Dysregulated iron metabolism has been associated with several ocular pathologies, including age-related macular degeneration, diabetic retinopathy, glaucoma, retinal detachment, cataracts, and anemic retinopathy. The eye possesses specialized iron regulatory mechanisms involving proteins such as transferrin, ferritin, ferroportin, and hepcidin that govern iron transport, storage, and export across ocular barriers. Aberrations in these pathways are now recognized as contributing factors in disease progression. This narrative review explores the complex dual role of iron overload and deficiency in ocular diseases. It highlights the molecular mechanisms underlying iron-mediated pathologies in both the posterior and anterior segments of the eye, along with the clinical manifestations of iron imbalance. Current therapeutic approaches are discussed, including oral and parenteral iron supplementation for deficiency and emerging chelation-based or antioxidant strategies to address iron overload, while highlighting their limitations. Key challenges remain in developing targeted ocular delivery systems that optimize bioavailability and minimize systemic toxicity. Hence, maintaining iron homeostasis is critical for visual function, and further research is needed to refine therapeutic interventions and clarify the mechanistic role of iron in ocular health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, School of Medicine, Saint Louis University, Saint Louis, MO 63104, USA.
ORCID-Profile: Ethan R Naquin, Richa Garg, William J Chen, Eshani Karmakar, Jaya P Gnana-Prakasam
Förderung
- NEI NIH HHS
- NIH HHS
- National Institute of Health
Zitieren
APA
Naquin, E. R., Garg, R., Chen, W. J., Karmakar, E., Prasad, A., Mandadi, S., Depala, K., Gopianand, J. S., & Gnana-Prakasam, J. P. (2025). Iron: More than Meets the Eye. Nutrients. https://doi.org/10.3390/nu17182964
Vancouver
Naquin ER, Garg R, Chen WJ, Karmakar E, Prasad A, Mandadi S, et al. Iron: More than Meets the Eye. Nutrients. 2025. doi:10.3390/nu17182964
BibTeX
@article{Naquin2025,
author = {Naquin, Ethan R and Garg, Richa and Chen, William J and Karmakar, Eshani and Prasad, Amogh and Mandadi, Saicharan and Depala, Kiran and Gopianand, Jyotsna S and Gnana-Prakasam, Jaya P},
title = {Iron: More than Meets the Eye},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17182964}
}
EUVIMED